Has John Kirby received payments from drug or device companies?

Yes. Drug and device makers reported $1,038 in general payments to John Kirby across 66 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Kirby did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Kirby come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Kirby

Gastroenterology · Mobile, ALNPI 1316995053

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 28.7% of the total. Reporting peaked in 2021 at $457 and has fallen 77.1% since, to $105 in 2022. That places this record below the midpoint for gastroenterology clinicians in AL, where the typical reported total is $3,384.

$1,038in general payments, 2019–2025

Across 66 payments — averaging $15.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$298
Takeda Pharmaceuticals U.S.A., Inc.$177
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$87
Ironwood Pharmaceuticals, Inc$85
Gilead$79
Nestle Healthcare Nutrition Inc.$77
plus $233 from 11 others

$32,946in research payments, 2019–2025

Across 7 payments — averaging $4706.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Vivus LLC$32K
AbbVie$1K

What the payments were for

Food & beverage$1,038100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	20	$298
Takeda Pharmaceuticals U.S.A., Inc.	12	$177
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	6	$87
Ironwood Pharmaceuticals, Inc	6	$85
Gilead	4	$79
Nestle Healthcare Nutrition Inc.	4	$77
Pfizer	3	$42
Shionogi Inc	2	$34
Evoke Pharma, Inc.	1	$30
Romark Laboratories, LC	1	$21
Braintree Laboratories, Inc.	1	$21
Mallinckrodt Hospital Products Inc.	1	$18
Redhill Biopharma Inc.	1	$16
Johnson & Johnson	1	$14
Intercept Pharmaceuticals, Inc.	1	$14
Amgen	1	$13
Ferring Pharmaceuticals Inc.	1	$12

How this compares

$1,038 in reported general payments places this provider in the 25th percentile of 225 gastroenterology providers in Alabama.

See all gastroenterology providers in Alabama →

Other gastroenterology in Mobile

Jack DipalmaMobile$903K
Phillip HendersonMobile$462K
William SonnierMobile$178K
Jorge HerreraMobile$167K
Matthew EvesMobile$46K
Michael SandersMobile$25K
Susan FleetMobile$15K
Jonathan SiegelMobile$15K
Panayiotis GrevenitisMobile$11K
Cody BarnettMobile$10K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →